Apollo Hospitals announced on 6 July 2022, a collaboration with Singapore-based ConnectedLife to integrate its cardiovascular risk assessment tool with the latter’s digital wellness solutions. Under the partnership, Apollo’s AICVD tool which can predict the risk of cardiovascular disease will be integrated with ConnectedLife’s digital solutions for wellness, condition management and other health-focused applications.
The company said in a statement that it will provide healthcare providers with the tools to predict the risk of cardiac disease in their patients and…
